
A full access package includes WHO policy guidance on the use of antigen-based rapid diagnostic tests, manufacturer volume guarantees for low and middle-income countries, catalytic funding to assist governments to deploy the tests and an initial US$50 million procurement fund Several rapid, point-o
Monday, 28 September 2020
Connect your wallet to join the discussion.
No comments yet. Be the first to share your take.